Georgejason/iStock Editorial via Getty Images Shares of Illumina ( NASDAQ: ILMN ) fell 6% post-market Monday after the company lowered its fiscal 2024 revenue guidance. The DNA sequencing company reported Q3 adjusted EPS of $1.14, which beat the Street consensus estimate by $0.
26. Revenue was in line with estimates at $1.08B, down 2.
7% from the.